Background: The Budd–Chiari syndrome (BCS) is hepatic venous outflow obstruction. What
is known about the syndrome is based on small studies of prevalent cases. Objective: To …

Budd–Chiari syndrome is a rare disease with a potentially dismal outcome if not treated
optimally. So far, diagnostic and intervention studies on Budd–Chiari syndrome have been small …

Background & Aims: Budd-Chiari syndrome (BCS) is a rare and life-threatening disorder
secondary to hepatic venous outflow obstruction. Small series of BCS patients indicate that …

Budd‐Chiari syndrome (BCS) is a rare, life‐threatening disease caused by obstruction of
hepatic venous outflow. The aim of the study was to assess long‐term outcome and identify …

Discussion The first report suggesting that systemic lupus erythematosus was exacerbated
by tetracyclines was in 1959. 4 This report of three cases suggested that tetracyclines might …

We describe mutations in the hepatitis B virus (HBV) polymerase gene in viruses which
reactivated in two patients during therapy with–2′–deoxy–3′–thiacytidine, or lamivudine (3TC)…

Acute intermittent porphyria occasionally causes frequent and crippling acute neurovisceral
attacks associated with increased hepatic production of porphyrin precursors, resulting in …

Background: We report our experience with management of patients with Budd Chiari
syndrome over the past two decades. In 1996 we described a novel approach involving …

Background. The literature data on the recurrence of autoimmune hepatitis (AIH) after orthotopic
liver transplantation (OLTX) is scanty. Methods. We analyzed the frequency of recurrent …

Transjugular intrahepatic portosystemic shunt (TIPS) have been shown to be an efficient
portal‐systemic derivative treatment for Budd‐Chiari syndrome (BCS) patients uncontrolled by …